These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9606494)
101. Iodine in the Treatment of Plague. Connor FP Ind Med Gaz; 1914 May; 49(5):208. PubMed ID: 29006399 [No Abstract] [Full Text] [Related]
102. Cardiac Failure in Plague and Its Treatment. Choksy NH Ind Med Gaz; 1905 Apr; 40(4):134-136. PubMed ID: 29004868 [No Abstract] [Full Text] [Related]
103. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice]. Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316 [TBL] [Abstract][Full Text] [Related]
104. [Effectiveness of cefotaxime in experimental plague infection]. Makarovskaia LN; Shcherbaniuk AI; Kasatkina IV; Zurabian VA Antibiot Khimioter; 1992 Nov; 37(11):24-6. PubMed ID: 1300929 [TBL] [Abstract][Full Text] [Related]
105. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1]. Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699 [TBL] [Abstract][Full Text] [Related]
106. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen]. Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704 [TBL] [Abstract][Full Text] [Related]
107. [Pathomorphological changes in albino mice infected with plague and treated with cefotaxime]. Makarovskaia LN; Sorokina TB; Zurabian VA; Ryzhkova VV; Markovskaia EI Antibiot Khimioter; 1998; 43(3):27-30. PubMed ID: 9606494 [TBL] [Abstract][Full Text] [Related]
108. [Cefotaxime: current status and future prospectives after 15 years of experience]. García-Rodríguez JA; García Sánchez JE; García Sánchez E; Fresnadillo MJ Rev Clin Esp; 1996 Jul; 196 Suppl 2():67-73. PubMed ID: 9558621 [No Abstract] [Full Text] [Related]
109. Assessment of the morphology and significance of the lymph nodal and hepatic lesions produced in rats by the feeding of certain mineral oils and waxes. Proceedings of a pathology workshop held at the Fraunhofer Institute of Toxicology and Aerosol Research Hannover, Germany, May 7-9, 2001. Carlton WW; Boitnott JK; Dungworth DL; Ernst H; Hayashi Y; Mohr U; Parodi AL; Pattengale PK; Rittinghausen S; Ward JM Exp Toxicol Pathol; 2001 Sep; 53(4):247-55. PubMed ID: 11665848 [TBL] [Abstract][Full Text] [Related]